{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:33:27Z","timestamp":1795160007136,"version":"4.10.3"},"reference-count":26,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2017,1,2]]},"DOI":"10.1080\/14740338.2017.1261824","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T14:19:51Z","timestamp":1479392391000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":57,"title":["Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis"],"prefix":"10.1080","volume":"16","author":[{"given":"H\u00e9l\u00e8ne","family":"Haguet","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium"},{"name":"Haematology Laboratory, Universit\u00e9 catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Douxfils","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mullier","sequence":"additional","affiliation":[{"name":"Haematology Laboratory, Universit\u00e9 catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Chatelain","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Graux","sequence":"additional","affiliation":[{"name":"Department of Haematology, Universit\u00e9 catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Dogn\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-594432"},{"key":"CIT0002","unstructured":"Australian Government. Australian public assessment report for Iclusig. 2015. [cited 2016 Nov 3]. Available from: https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-ponatinib-150416.docx"},{"issue":"2","key":"CIT0003","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1007\/s00277-015-2314-2","volume":"94","author":"Hoglund M","year":"2015","journal-title":"Ann Hematol"},{"issue":"4","key":"CIT0004","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1002\/ajh.23938","volume":"90","author":"Cortes J","year":"2015","journal-title":"Am J Hematol"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5932"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12698"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-601674"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00080-2"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.5"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12423"},{"issue":"21","key":"CIT0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V124.21.517.517","volume":"124","author":"O\u2019Brien SG","year":"2014","journal-title":"Blood"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.1011"},{"key":"CIT0014","unstructured":"Avillion. Avillion announces dosing of first patients in phase 3 BFORE trial to assess BOSULIF\u00ae (bosutinib) as first-line treatment for patients with chronic myelogenous leukemia. 2014 Aug 11. [cited 2]. Available from: http:\/\/avillionllp.com\/news\/avillion-announces-dosing-of-first-patients-in-phase-3-bfore-trial-to-asses"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000124105.39900.db"},{"issue":"1","key":"CIT0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.115.012039","volume":"68","author":"Gacic J","year":"2016","journal-title":"Pr"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-007-9080-2"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.69"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.2219"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8899"},{"key":"CIT0022","unstructured":"EMA. European Medicines Agency recommends changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise risk of blood clots. 2013 11 22. [cited 2014 10.18]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2013\/11\/WC500155451.pdf"},{"key":"CIT0023","first-page":"1","volume":"1","author":"Pasvolsky O","year":"2015","journal-title":"Cardiooncology"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2015.11.008"},{"issue":"8","key":"CIT0025","first-page":"927","volume":"5","author":"Rafieian-Kopaei M","year":"2014","journal-title":"Int J Prev Med"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2231-9"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2017.1261824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T19:21:26Z","timestamp":1597605686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2017.1261824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,2]]}},"alternative-id":["10.1080\/14740338.2017.1261824"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2017.1261824","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}